CD274 and neoplasm: Studies have demonstrated that low doses of fractionated RT can lead to an adaptive upregulation of tumor cell PD-L1 expression that is dependent on CD8+ T-cell production of IFNγ, which may attenuate the efficacy of the anticancer immune response.